1/4/2013

Lantheus Medical Imaging has renewed its long-term licensing and distribution deal with Fujifilm RI Pharma covering SPECT imaging agents Cardiolite and Neurolite. As part of the 10-year deal, which took effect Jan. 1, Lantheus will keep providing FRI with the agents in finished form for distribution in Japan. Lantheus will also supply raw materials for developing and marketing in unit dose format.

Related Summaries